IPG Photonics Corporation (BVMF:I1PG34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 16.46B -12.2% |
| Revenue (ttm) | 5.54B +13.0% |
| Net Income | 142.78M |
| EPS | 3.36 |
| Shares Out | n/a |
| PE Ratio | 115.31 |
| Forward PE | 39.09 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2 |
| Open | 194.00 |
| Previous Close | n/a |
| Day's Range | 194.00 - 194.00 |
| 52-Week Range | 180.00 - 320.50 |
| Beta | 1.00 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 4, 2026 |
About IPG Photonics
IPG Photonics Corporation develops, manufactures, and sells fiber lasers, fiber amplifiers, diode lasers, and laser-based systems used in materials processing, medical, and advanced applications. The company offers laser products, including hybrid fiber-solid state lasers with green and ultraviolet wavelengths; fiber pigtailed packaged diodes and fiber coupled direct diode laser systems; and high-energy pulsed lasers, multi-wavelength and tunable lasers, and single-polarization and single-frequency lasers, as well as other versions. It also pro... [Read more]
News
IPG Photonics management to meet with Needham
Meeting to be held in Boston on August 13 hosted by Needham.
IPG Photonics price target lowered to $137 from $150 at Citi
Citi lowered the firm’s price target on IPG Photonics (IPGP) to $137 from $150 and keeps a Buy rating on the shares.
IPG Photonics Earnings Call Transcript: Q2 2026
Revenue grew 11% year-over-year to $279 million, with strong industrial and advanced solutions demand and bookings keeping book-to-bill above one. Adjusted gross margin and EPS exceeded guidance, and the Lumibird Medical acquisition is set to expand high-margin medical revenue.
IPG Photonics Earnings release: Q2 2026
IPG Photonics released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
IPG Photonics Slides: Q2 2026
IPG Photonics has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
IPG Photonics Quarterly report: Q2 2026
IPG Photonics has published its Q2 2026 quarterly earnings report on August 4, 2026.
IPG Photonics reports Q2 adjusted EPS 58c, consensus 39c
Reports Q2 revenue $278.58M, consensus $279.97M. “We delivered our third consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance and adjusted...
IPG Photonics sees Q3 adjusted EPS 30c-60c, consensus 43c
Sees Q3 revenue $265M-$295M, consensus $276.6M. “Our book-to-bill remained above one in the second quarter, pointing to ongoing robust demand for our solutions and the team’s focused execution of our…
IPG Photonics Announces Second Quarter 2026 Financial Results
Improving Industrial Demand and Continued Focus on Strategic Initiatives Drive Results Managing Costs and Driving Gross Margin Improvement MARLBOROUGH, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- IPG Pho...
IPG Photonics to Announce Second Quarter 2026 Financial Results on August 4
MARLBOROUGH, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP) will release its second quarter 2026 financial results before the market opens on Tuesday, August 4, 2026...
IPG Photonics price target raised to $120 from $110 at Needham
Needham raised the firm’s price target on IPG Photonics (IPGP) to $120 from $110 and keeps a Buy rating on the shares, following the company’s agreement to acquire Lumibird Medical…
IPG Photonics Transcript: M&A announcement
The acquisition of Lumibird Medical for €300 million expands the acquirer's medical laser platform into ophthalmology, increasing its addressable market by $1 billion and boosting advanced solutions revenue to 26% of sales. The deal is expected to be accretive in year one and positions the company for long-term growth and innovation.
IPG Photonics Slides: M&A announcement
IPG Photonics has posted slides in relation to its latest quarterly earnings report, which was published on July 17, 2026.
IPG Photonics Press release: M&A announcement
IPG Photonics issued a press release on July 17, 2026, disclosing material business information to investors.
IPG Photonics to acquire Lumibird Medical
IPG Photonics (IPGP) has entered into a binding offer to acquire Lumibird Medical. The transaction is expected to deliver financial benefits by adding a high-margin business that is accretive to…
IPG Photonics Announces Binding Offer to Acquire Lumibird Medical, Expanding IPG's Medical Laser Growth Platform
Creates a Scaled Medical Laser Platform, Accelerating IPG's Strategic Expansion in Advanced Solutions Expected to Be Accretive to Gross Margin, EBITDA, and Adjusted EPS MARLBOROUGH, Mass., July 16, 20...
IPG Photonics price target raised to $151 from $149 at Roth Capital
Roth Capital raised the firm’s price target on IPG Photonics (IPGP) to $151 from $149 and keeps a Buy rating on the shares. The firm says it is seeing the…
IPG Photonics selloff on Q1 report unwarranted, says Citi
Citi analyst Jamie Wang views the post-earnings selloff in shares of IPG Photonics (IPGP) as unwarranted. Citi believes IPG should continue to benefit from rising laser source demand. It reiterates…
IPG Photonics price target raised to $150 from $105 at Citi
Citi raised the firm’s price target on IPG Photonics (IPGP) to $150 from $105 and keeps a Buy rating on the shares.
IPG Photonics price target lowered to $125 from $165 at Stifel
Stifel lowered the firm’s price target on IPG Photonics (IPGP) to $125 from $165 and keeps a Buy rating on the shares.
IPG Photonics upgraded to Buy from Hold at Needham
Needham upgraded IPG Photonics (IPGP) to Buy from Hold with a $110 price target The firm cites its “growing confidence” in the company’s sales prospects for the upgrade after it…
IPG Photonics price target lowered to $160 from $180 at Raymond James
Raymond James lowered the firm’s price target on IPG Photonics (IPGP) to $160 from $180 and keeps an Outperform rating on the shares. IPG Photonics reported a mixed Q1 with…
IPG Photonics falls -25.8%
IPG Photonics (IPGP) is down -25.8%, or -$31.62 to $90.71.
IPG Photonics falls -25.8%
IPG Photonics (IPGP) is down -25.8%, or -$31.53 to $90.80.
IPG Photonics Earnings Call Transcript: Q1 2026
Revenue grew 17% year-over-year, led by industrial solutions and strong demand in battery and medical markets. Bookings and backlog remain robust, with Q2 guidance reflecting continued momentum despite tariff and macroeconomic headwinds.